Rising innovators in the marijuana and psychedelics space will present their latest research and policy findings during the second annual Cannabis Policy Institute student showcase.

From soldiers returning home from a tour suddenly haunted by the full weight of what they endured, to police officers, paramedics and firefighters grappling with casualties they were ultimately powerless to prevent, Nevada’s veteran and first responder communities carry a heavy mental health burden that too often hides in plain sight.

THCV has one of the boldest sales pitches in cannabis and hemp right now. Depending on the package, it’s supposed to give you energy, sharpen your focus, keep you productive, and stop you from demolishing every snack in the house.

In 2018, after 23 years as a Navy SEAL, Jon Dalton retired and turned his attention to a new struggle: living with depression and anxiety.

For decades, the federal government considered marijuana as dangerous a drug as heroin. That changed Thursday when the acting U.S. Attorney General Todd Blanchard signed an order reclassifying state-licensed cannabis products from schedule I to a far less regulated schedule III. The order does not legalize marijuana for medical or recreational use under federal law, but it does ease some barriers to cannabis research. And that came as very good news for a pair of UNLV scientists.

Researchers at UNLV are trying to determine if a kitchen spice could become a way to treat seizures.

Within the white, clinical walls of a nondescript UNLV lab, a small team of neuroscientists are working on a project with potentially big implications for children suffering from seizures.

Dr. Dustin Hines, professor of neuroscience at University of Nevada, Las Vegas (UNLV), US, and study co-author Rochelle Hines, professor of psychology, discuss a breakthrough in seizure therapy using compounds derived from caraway seeds. By altering the shape of the seed’s main chemical component, researchers created a new class of THC-free “CBD-like” therapies that showed seizure-reducing effects and promoted healthier brain cell development in preclinical trials, potentially offering safer alternatives to current drug-resistant therapies.